Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.
Sanofi-Aventis, Population Health Research Institute, and Canadian Network for Trials Internationally (CANNeCTIN), an initiative of the Canadian Institutes of Health Research.
Jolly, S. S., Yusuf, S., Cairns, J., Niemelä, K., Xavier, D., Widimsky, P., Budaj, A., Niemelä, M., Valentin, V., Lewis, B. S., Avezum, A., Steg, P. G., Rao, S. V., Gao, P., Afzal, R., Joyner, C. D., Chrolavicius, S., Mehta, S. R., & RIVAL. (2011). Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. The Lancet, 377(9775), 1409-1420. https://doi.org/10.1016/S0140-6736(11)60404-2 (Original work published 2011)